Tokyo, Oct. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063193) titled 'Bronchiectasis Understanding and Research on Daily Experiences and Needs(BURDEN) : Online survey in Japanese patients with bronchiectasis(J-BURDEN Initiative Study)' on Oct. 8.
Study Type:
Observational
Primary Sponsor:
Institute - Insmed GK.
Condition:
Condition - Bronchiectasis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the stable-state daily burden and the incremental burden of exacerbations among Japanese patients with non-cystic fibrosis bronchiectasis (NCFBE). This exploratory study also aims to identify associations between patient characteristics and disease burden.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1.Confirmed diagnosis of bronchiectasis (without cystic fibrosis [CF]).
2.Currently symptomatic NCFBE.
3.At least one pulmonary exacerbation within the past year.
4.Aged 18 years or older at the time of providing consent.
5.Currently residing in Japan.
6.Able to understand written Japanese and self-complete the questionnaires.
7.Willing to participate in the study as evidenced by the consent process.
Key exclusion criteria - 1.Diagnosis of cystic fibrosis.
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 28 Day
Date of IRB - 2026 Year 09 Month 16 Day
Anticipated trial start date - 2026 Year 10 Month 13 Day
Last follow-up date - 2026 Year 10 Month 19 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072263
Disclaimer: Curated by HT Syndication.
